Previous Close | 59.36 |
1-Year Change | 77.67% |
6-Months Change | 56.87% |
3-Months Change | 34.33% |
Moving Avg (50d) | 52.944 |
Moving Avg (200d) | 45.698 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 3.51B |
Beta (3-Years) | 1.32 |
Revenue Growth (ttm) | 271.94% |
Net Profit Margin (ttm) | -299.33% |
Return On Assets (ttm) | -52.38% |
EPS (ttm) | -3.24 |
PE Ratio (ttm) | -18.32 |
Dividend Yield | % |
Asset Description: | Rhythm Pharmaceuticals, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-11-19 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
58.741 | 56.943 | 55.744 | 53.946 | 50.949 | 47.952 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |